Skip to content

The clinical research of Mongolian medicine in treating bradyarrhythmia

Research on Modernization of Traditional Chinese Medicine: Clinical Research on Mongolian Medicine in Treating Bradyarrhythmia and Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052939
Enrollment
Unknown
Registered
2021-11-06
Start date
2019-05-01
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmia

Interventions

experimental group:Mongolian Medicine Ganlu Shengmaiwan
control group:Traditional Chinese Medicine Xinbaowan

Sponsors

Inner Mongolia International Mongolian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Refer to "Internal Medicine" "Ge Junbo, Xu Yongjian. People's Medical Publishing House 2014:197-227" 1. Sinus bradycardia 1.1 Heart rate is less than 60 beats/min, normal P wave; 1.2. The P-R interval is within 0.120.20s; 1.3 Often accompanied by sinus arrhythmia. 2. Atrioventricular block 2.1 I degree atrioventricular block: Normal P waves have corresponding QRS complexes thereafter; the P-R interval is extended to more than 0.20 seconds, and the heart rate is less than 60 beats/min. 2.2 Type II degree I: The P-R interval is gradually extended until the P wave is blocked; the R-R interval is gradually shortened until the P wave is blocked; the long R-R is greater than 2 times the short R-R; the QRS waveform is normal (unless bundle branch block is combined). 2.3 Type II degree II: P-R interval conduction is equal, and P wave is blocked; atrioventricular conduction ratio can be constant or not fixed; QRS waveform can be normal, widened, and deformed branch block. ?The heart rate is less than 60 beats/min. 2.4 III degree atrioventricular block Atrioventricular separation, the frequency of P-P and R-R is fixed, the atrial rate is faster than the ventricular rate, and the ventricular rate is generally slow and regular (30-60 beats/min); the P wave has nothing to do with the QRS complex. QRS complex morphology can be normal (block above the atrioventricular branch) or abnormally widened (block below the atrioventricular bundle branch) 3. Sick sinus syndrome Mainly manifested in sinus node dysfunction, when several or one of the following conditions occur at the same time, and it is not because Caused by drugs or metabolic function and neurological disorders: 3.1 Sinus block. 3.2 Normal ECG or 24-hour Holter ECG shows that the time of sinus arrest often exceeds 2s. 3.3 Long-term sinus bradycardia occurs. A large part of sinus rhythm within 24 hours is =50 beats/min, and occasionally increases to 60 to 70 beats/min. This situation can be continuous or intermittent. 3.4 The heart rate of most patients after the atropine test is not as high as normal, usually = 90 beats/min. 4. Other types of bradycardia In addition to the above reasons, some arrhythmias with a ventricular rate of less than 60 beats/min. The common ones are slow atrial fibrillation. 5. the diagnostic criteria of Mongolian medicine It is formulated in accordance with "Mongolian Medicine Disease Diagnosis and Efficacy Standards" and "Mongolian Medicine Internal Medicine". Main symptoms: (1)Palpitation; (2)Dizziness and forgetfulness; Secondary symptoms: (1)Chest tightness;(2) Fatigue;(3) Pale face;(4) Cold limbs;(5) Even dark and fainting; Pulse, tongue and urine: slow pulse; white tongue with thick coating; white urine with light odor. 1 item is necessary for the main symptom, at least 1 item is necessary for the secondary symptom, and at least 1 item is necessary for the secondary symptom.

Exclusion criteria

Exclusion criteria: 1. The age is less than 18 years old and more than 85 years old; 2. Those who need to use other methods to treat arrhythmia drugs; 3. Patients with severe primary diseases of liver, lung, kidney, blood system or diseases that affect their survival, among which blood ALT, AST>1.5 times the upper limit of normal, blood Cr>upper limit of normal; 4. Acute and chronic heart failure, other system diseases (such as anemia, hyperthyroidism and hypothyroidism), digitalis poisoning, severe electrolyte imbalance, etc.; 5. Pregnant and lactating women or those who have recently had a childbirth plan; 6. Unstable blood pressure control (systolic blood pressure greater than or equal to 170mmHg; diastolic blood pressure greater than or equal to 105mmHg); 7. People with allergies and multiple drug allergies; 8. Special populations who are not suitable for participating in clinical research (blind, deaf, dumb, mentally handicapped, mentally handicapped, etc.); 9. Failure to take medications according to regulations, incomplete case data, etc., which affect the judgment of clinical efficacy; 10. Those who participated in other clinical trials within 3 months before participating in this study.

Design outcomes

Primary

MeasureTime frame
24-hour Holter ECG;Mongolian medicine syndrome;

Countries

China

Contacts

Public ContactNashundalai

Inner Mongolia International Mongolian Hospital

1045321506@qq.com+86 13848913897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026